Biodexa Pharmaceticals Stock Alpha and Beta Analysis
| BDRX Stock | 4.16 0.24 5.45% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biodexa Pharmaceticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biodexa Pharmaceticals over a specified time horizon. Remember, high Biodexa Pharmaceticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biodexa Pharmaceticals' market risk premium analysis include:
Beta 0.89 | Alpha (0.78) | Risk 6.62 | Sharpe Ratio (0.07) | Expected Return (0.47) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Biodexa |
Biodexa Pharmaceticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biodexa Pharmaceticals market risk premium is the additional return an investor will receive from holding Biodexa Pharmaceticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biodexa Pharmaceticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biodexa Pharmaceticals' performance over market.| α | -0.78 | β | 0.89 |
Biodexa Pharmaceticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Biodexa Pharmaceticals' Buy-and-hold return. Our buy-and-hold chart shows how Biodexa Pharmaceticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Biodexa Pharmaceticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Biodexa Pharmaceticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biodexa Pharmaceticals shares will generate the highest return on investment. By understating and applying Biodexa Pharmaceticals stock market price indicators, traders can identify Biodexa Pharmaceticals position entry and exit signals to maximize returns.
Biodexa Pharmaceticals Return and Market Media
The median price of Biodexa Pharmaceticals for the period between Fri, Oct 25, 2024 and Thu, Jan 23, 2025 is 4.7 with a coefficient of variation of 19.78. The daily time series for the period is distributed with a sample standard deviation of 0.98, arithmetic mean of 4.96, and mean deviation of 0.8. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Levi Korsinsky Reminds Biodexa Pharmaceuticals Plc Investors of the Ongoing Investigation into Potential Violations of Securities Laws - BDRX | 10/30/2024 |
2 | Biodexa Pharmaceuticals Plc Short Interest Down 50.2 percent in October | 11/14/2024 |
3 | Biodexa Pharmaceuticals Adjusts Share Value Amid Drug Development Focus - TipRanks | 12/04/2024 |
4 | Biodexa Pharmaceuticals files to sell 35.9M ADS for holders | 01/17/2025 |
About Biodexa Pharmaceticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biodexa or other stocks. Alpha measures the amount that position in Biodexa Pharmaceticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 171.8 | 674.44 | 775.6 | 814.38 | PTB Ratio | 25.45 | 0.36 | 0.41 | 0.39 |
Biodexa Pharmaceticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Biodexa Pharmaceticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biodexa Pharmaceticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Biodexa Pharmaceticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Biodexa Pharmaceticals. Please utilize our Beneish M Score to check the likelihood of Biodexa Pharmaceticals' management manipulating its earnings.
| 26th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Biodexa Pharmaceticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Biodexa Stock Analysis
When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.